NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,117,164 | -2.0% | 20,785 | -2.9% | 0.60% | -4.8% |
Q2 2023 | $2,159,983 | +2.6% | 21,405 | -6.4% | 0.63% | -4.4% |
Q1 2023 | $2,104,228 | -16.8% | 22,872 | -17.9% | 0.66% | -22.3% |
Q4 2022 | $2,527,917 | -17.9% | 27,865 | -31.2% | 0.84% | -30.0% |
Q3 2022 | $3,079,000 | -19.3% | 40,505 | -10.3% | 1.21% | -18.2% |
Q2 2022 | $3,815,000 | -36.1% | 45,131 | -33.7% | 1.47% | -34.6% |
Q1 2022 | $5,974,000 | -2.1% | 68,078 | -2.4% | 2.25% | -6.0% |
Q4 2021 | $6,103,000 | +12.5% | 69,772 | +5.2% | 2.40% | -4.8% |
Q3 2021 | $5,423,000 | -8.6% | 66,309 | +2.0% | 2.52% | -7.8% |
Q2 2021 | $5,934,000 | +5.9% | 65,037 | -0.8% | 2.73% | -4.8% |
Q1 2021 | $5,603,000 | +27.4% | 65,551 | +40.7% | 2.87% | -11.9% |
Q4 2020 | $4,399,000 | +14.3% | 46,588 | +5.3% | 3.25% | +4.9% |
Q3 2020 | $3,849,000 | +7.0% | 44,258 | +7.5% | 3.10% | -9.9% |
Q2 2020 | $3,596,000 | +17.2% | 41,170 | +10.6% | 3.44% | -12.6% |
Q1 2020 | $3,069,000 | -5.7% | 37,219 | +8.3% | 3.94% | +9.5% |
Q4 2019 | $3,253,000 | – | 34,352 | – | 3.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
Elefante Mark B | 5,619 | $417,000 | 3.78% |
SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |